Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microbiome and cancer
Nyssa Cullin, Camila Azevedo Antunes, Ravid Straussman, et al.
Cancer Cell (2021) Vol. 39, Iss. 10, pp. 1317-1341
Open Access | Times Cited: 336

Showing 1-25 of 336 citing articles:

Meta-hallmarks of aging and cancer
Carlos López-Otı́n, Federico Pietrocola, David Roiz‐Valle, et al.
Cell Metabolism (2023) Vol. 35, Iss. 1, pp. 12-35
Open Access | Times Cited: 233
Reuterin in the healthy gut microbiome suppresses colorectal cancer growth through altering redox balance
Hannah N. Bell, Ryan Rebernick, Joshua Goyert, et al.
Cancer Cell (2021) Vol. 40, Iss. 2, pp. 185-200.e6
Open Access | Times Cited: 171
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021
Qing Wu, Wei Qian, Xiaoli Sun, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 125
The coming decade in precision oncology: six riddles
Adam Wahida, Lars Buschhorn, Stefan Fröhling, et al.
Nature reviews. Cancer (2022) Vol. 23, Iss. 1, pp. 43-54
Closed Access | Times Cited: 125
Mechanisms driving the immunoregulatory function of cancer cells
Antoinette van Weverwijk, Karin E. de Visser
Nature reviews. Cancer (2023) Vol. 23, Iss. 4, pp. 193-215
Closed Access | Times Cited: 122
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy
Christoph K. Stein‐Thoeringer, Neeraj Saini, Eli Zamir, et al.
Nature Medicine (2023) Vol. 29, Iss. 4, pp. 906-916
Open Access | Times Cited: 104
Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis
Weibo Zhong, Kaihui Wu, Zining Long, et al.
Microbiome (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 96
Immunology and immunotherapy of cholangiocarcinoma
Tim F. Greten, Robert F. Schwabe, Nabeel Bardeesy, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 6, pp. 349-365
Closed Access | Times Cited: 81
The intratumor mycobiome promotes lung cancer progression via myeloid-derived suppressor cells
Ning‐Ning Liu, Cheng-Xiang Yi, Luqi Wei, et al.
Cancer Cell (2023) Vol. 41, Iss. 11, pp. 1927-1944.e9
Open Access | Times Cited: 68
Current understanding of the intratumoral microbiome in various tumors
Xue Chen, Qingfei Chu, Qiuxian Zheng, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 1, pp. 100884-100884
Open Access | Times Cited: 63
Recent Advances and Clinical Potential of Near Infrared Photothermal Conversion Materials for Photothermal Hepatocellular Carcinoma Therapy
Ruiliang Ge, Pei-ning Yan, Yang Liu, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 29
Closed Access | Times Cited: 48
Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors
Rebecca Simpson, Erin R. Shanahan, Richard A. Scolyer, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 10, pp. 697-715
Closed Access | Times Cited: 45
Injectable nano-composite hydrogels based on hyaluronic acid-chitosan derivatives for simultaneous photothermal-chemo therapy of cancer with anti-inflammatory capacity
Liduo Rong, Yao Liu, Yu Fan, et al.
Carbohydrate Polymers (2023) Vol. 310, pp. 120721-120721
Closed Access | Times Cited: 41
Bile acids modified by the intestinal microbiota promote colorectal cancer growth by suppressing CD8+ T cell effector functions
Jingjing Cong, Pianpian Liu, Zili Han, et al.
Immunity (2024) Vol. 57, Iss. 4, pp. 876-889.e11
Closed Access | Times Cited: 39
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Shaosen Zhang, Xinyi Xiao, Yonglin Yi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 31
Multiplex protein imaging in tumour biology
Natalie de Souza, Shan Zhao, Bernd Bodenmiller
Nature reviews. Cancer (2024) Vol. 24, Iss. 3, pp. 171-191
Closed Access | Times Cited: 19
Development of tumor-evolution-targeted anticancer therapeutic nanomedicineEVT
Lingpu Zhang, Jia‐Zhen Yang, Jia Huang, et al.
Chem (2024) Vol. 10, Iss. 5, pp. 1337-1356
Closed Access | Times Cited: 17
In situ targeted base editing of bacteria in the mouse gut
Andreas K. Brödel, Loïc H. Charpenay, Matthieu Galtier, et al.
Nature (2024) Vol. 632, Iss. 8026, pp. 877-884
Open Access | Times Cited: 17
Critical role of the gut microbiota in immune responses and cancer immunotherapy
Ze-Hua Li, Weixi Xiong, Liang Zhu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 16
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 14
Robustness of cancer microbiome signals over a broad range of methodological variation
Gregory D. Sepich‐Poore, Daniel McDonald, Evguenia Kopylova, et al.
Oncogene (2024) Vol. 43, Iss. 15, pp. 1127-1148
Open Access | Times Cited: 13
Methanogenic archaea in the human gastrointestinal tract
Christoph Höegenauer, Heinz F. Hammer, Alexander Mahnert, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 12, pp. 805-813
Closed Access | Times Cited: 57
A dysbiotic microbiome promotes head and neck squamous cell carcinoma
Daniel N. Frank, Yue Qiu, Yu Cao, et al.
Oncogene (2022) Vol. 41, Iss. 9, pp. 1269-1280
Open Access | Times Cited: 50
Cancer as microenvironmental, systemic and environmental diseases: opportunity for transdisciplinary microbiomics science
Kentaro Inamura, Tsuyoshi Hamada, Susan Bullman, et al.
Gut (2022) Vol. 71, Iss. 10, pp. 2107-2122
Open Access | Times Cited: 49
The heightened importance of the microbiome in cancer immunotherapy
C Villemin, Anne Six, Bridget A. Neville, et al.
Trends in Immunology (2022) Vol. 44, Iss. 1, pp. 44-59
Open Access | Times Cited: 47
Page 1 - Next Page

Scroll to top